We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Monday
May 05
09:00 - 10:00
Stolz 1
Head & neck 3
Mariangela Massaccesi, Italy;
Panagiotis Balermpas, Switzerland
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will be recorded and made available via the online platform and mobile app.
Mini-Orals
Clinical
Head & Neck
09:00 - 09:07
High-dose hypofractionated radiotherapy for palliation or primary treatment in 944 head and neck cancer patients with poor performance status
Jørgen Johansen, Denmark
E25-3063
09:07 - 09:14
Adaptive dose painting by numbers for head and neck cancer: long term analysis of a randomized trial.
Fréderic Duprez, Belgium
E25-1251
09:14 - 09:21
HERVIN: variability in target selection and delineation for head and neck cancer radiotherapy in Europe
Gaber Plavc, Slovenia
E25-3833
09:21 - 09:28
Radiotherapy-induced cGAS re-localization and immune signature as predictor for HNSCC treatment efficacy
Gosse Adema, The Netherlands
E25-3861
09:28 - 09:35
Clinical Feasibility and Dosimetric Benefits of Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma
Guanqun Zhou, China
E25-1726
09:35 - 09:42
Patterns of failure after radiotherapy for nasopharyngeal carcinoma in a low-incidence population: A national DAHANCA analysis (Denmark, 2000-2018)
Anne Marie Lindegaard, Denmark
E25-3374
09:42 - 09:49
Nomogram for estimation of the locoregional control and survival benefit following post-operative radiation therapy for pN0 oral cavity cancer.
max gau, Canada
E25-1671
09:49 - 09:56
Involved neck only versus mucosal radiotherapy for HNSCCUP: a national multicentre review of primary emergence, failure patterns and toxicity rates
Claire Paterson, United Kingdom
E25-1208